2 Paths of Bayer Drug in 80's: Riskier Type Went Overseas
By WALT BOGDANICH and ERIC KOLI
division of the pharmaceutical company Bayer sold millions of dollars of blood-clotting medicine for hemophiliacs — medicine that carried a high risk
of transmitting AIDS — to Asia and Latin America in the mid-1980's while selling a new, safer product in the West, according to documents obtained by
The New York Times.
The Bayer unit, Cutter Biological, introduced its safer medicine in late February 1984 as evidence mounted that the earlier version was infecting
hemophiliacs with H.I.V. Yet for over a year, the company continued to sell the old medicine overseas, prompting a United States regulator to accuse
Cutter of breaking its promise to stop selling the product.
www.nytimes.com... 
